Analysts expect Pharming Group N.V. to report revenue of 104.08 M for Q4 26, against a range of 94.34 M to 113.81 M. The most recent reported quarter, Q3 26, came in at 117.60 M, a 4.6% beat against the 112.41 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 92.70 M | 79.09 M | 93.20 M | 97.30 M | 106.50 M | 72.45 M | 90.20 M | 117.60 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 86.69 M | 76.60 M | 85.88 M | 112.74 M | 120.80 M | 100.48 M | 109.75 M | 118.31 M | 113.81 M | 92.51 M | 102.23 M | 115.49 M | 114.39 M | 82.08 M | 96.60 M | 109.85 M | |||||||||
| Low Estimate | 71.40 M | 65.13 M | 72.03 M | 92.68 M | 110.90 M | 88.86 M | 96.07 M | 106.51 M | 94.34 M | 79.22 M | 83.88 M | 100.48 M | 97.26 M | 73.88 M | 85.35 M | 101.02 M | |||||||||
| Consensus Estimate | 79.04 M | 70.87 M | 78.96 M | 102.71 M | 115.85 M | 94.67 M | 102.91 M | 112.41 M | 104.08 M | 85.86 M | 93.06 M | 107.98 M | 105.83 M | 77.98 M | 90.98 M | 105.44 M |
Analysts expect Pharming Group N.V. to report earnings per share of 0.10 for Q4 26, against a range of 0.09 to 0.11. The most recent reported quarter, Q3 26, came in at 0.30, a 36.4% beat against the 0.22 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.05 | -0.22 | 0.06 | 0.10 | 0.07 | -0.07 | 0.02 | 0.30 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.02 | -0.03 | -0.09 | 0.00 | 0.01 | 0.00 | 0.06 | 0.24 | 0.11 | -0.09 | 0.11 | 0.32 | 0.16 | -0.07 | 0.13 | 0.31 | |||||||||
| Low Estimate | 0.02 | -0.03 | -0.09 | 0.00 | 0.01 | 0.00 | 0.06 | 0.20 | 0.09 | -0.11 | 0.09 | 0.26 | 0.14 | -0.09 | 0.11 | 0.29 | |||||||||
| Consensus Estimate | 0.02 | -0.03 | -0.09 | 0.00 | 0.01 | 0.00 | 0.06 | 0.22 | 0.10 | -0.10 | 0.10 | 0.29 | 0.15 | -0.08 | 0.12 | 0.30 |
Pull Wall Street consensus for Pharming Group N.V. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PHAR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PHAR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PHAR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();